Disclosing Accelerated Approval on Direct-to-Consumer Prescription Drug Websites

Documenti analoghi

• Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites
  di: Sullivan, Helen W., et al.
  Pubblicazione: (2017)
• Consumers’ Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads
  di: O’Donoghue, Amie C., et al.
  Pubblicazione: (2016)
• Randomized Study of Placebo and Framing Information in Direct-to-Consumer Print Advertisements for Prescription Drugs
  di: O’Donoghue, Amie C., et al.
  Pubblicazione: (2014)
• Effects of Comparative Claims in Prescription Drug Direct-to-Consumer Advertising on Consumer Perceptions and Recall
  di: O’Donoghue, Amie C., et al.
  Pubblicazione: (2014)
• Consumer Confusion between Prescription Drug Precautions and Side Effects
  di: Amoozegar, Jacqueline B., et al.
  Pubblicazione: (2016)